STOCK TITAN

[8-K] Scienture Holdings, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Scienture Holdings (SCNX) disclosed it received a Nasdaq notice that its common stock failed to meet the $1.00 minimum bid price for 30 consecutive business days, triggering a compliance period. The company has 180 calendar days, until April 13, 2026, to regain compliance by maintaining a closing bid at or above $1.00 for at least ten consecutive business days.

The notice has no immediate effect on the listing or trading of the stock on Nasdaq. Scienture believes it can regain compliance, while noting there is no assurance it will meet the requirement or other Nasdaq criteria.

Scienture Holdings (SCNX) ha comunicato di aver ricevuto una notifica Nasdaq per cui il suo titolo azionario comune non ha rispettato il prezzo minimo di negoziazione di $1,00 per 30 giorni lavorativi consecutivi, attivando un periodo di conformità. L'azienda ha 180 giorni di calendario, fino al 13 aprile 2026, per ritornare a conformità mantenendo una chiusura di negoziazione pari o superiore a $1,00 per almeno dieci giorni lavorativi consecutivi.

La notifica non ha effetto immediato sulla quotazione o sul trading del titolo su Nasdaq. Scienture ritiene di poter ritornare in conformità, pur rilevando che non vi è alcuna garanzia che verrà soddisfatto il requisito o altri criteri Nasdaq.

Scienture Holdings (SCNX) anunció haber recibido una notificación de Nasdaq que su acción ordinaria no cumplió con el precio mínimo de puja de $1.00 durante 30 días hábiles consecutivos, desencadenando un periodo de cumplimiento. La empresa tiene 180 días naturales, hasta el 13 de abril de 2026, para volver a cumplir manteniendo un precio de cierre de al menos $1.00 por diez días hábiles consecutivos.

La notificación no tiene efecto inmediato en la cotización ni en el listado en Nasdaq. Scienture cree que puede volver a cumplir, aunque advierte que no hay garantía de que se cumpla el requisito u otros criterios de Nasdaq.

Scienture Holdings (SCNX)는 보통주가 30영업일 연속으로 $1.00의 최저 호가를 충족하지 못했다는 나스닥 통지를 받았으며, 이를 통해 규정 준수 기간이 시작되었습니다. 이 회사는 180일의 캘린더링 기간이 남아 있으며, 2026년 4월 13일까지, 최소 $1.00의 종가를 10영업일 연속 유지하여 규정 준수를 회복할 수 있습니다.

이 통지는 나스닥에서의 상장 또는 거래에 즉시 영향을 주지 않습니다. Scienture은 규정을 회복할 수 있을 것으로 믿고 있으며, 요구사항이나 다른 나스닥 기준을 충족할 것이라는 보장은 없다고 덧붙입니다.

Scienture Holdings (SCNX) a publié avoir reçu un avis de Nasdaq indiquant que son action ordinaire n'a pas respecté le prix d'offre minimum de $1,00 sur 30 jours ouvrables consécutifs, déclenchant une période de conformité. La société dispose de 180 jours calendaires, jusqu'au 13 avril 2026, pour retrouver la conformité en maintenant un cours de clôture au moins égal à $1,00 pendant au moins dix jours ouvrables consécutifs.

Cet avis n'a pas d'effet immédiat sur l'inscription ou la négociation des actions sur Nasdaq. Scienture estime pouvoir retrouver la conformité, tout en notant qu'il n'y a aucune assurance qu'elle remplira l'exigence ou d'autres critères de Nasdaq.

Scienture Holdings (SCNX) gab bekannt, dass es eine Nasdaq-Mitteilung erhalten hat, wonach seine Stammaktie in 30 aufeinanderfolgenden Handelstagen den Mindestangebotspreis von $1,00 nicht erreicht hat, wodurch eine Compliance-Periode ausgelöst wurde. Das Unternehmen hat 180 Kalendertage bis zum 13. April 2026, um die Einhaltung wiederherzustellen, indem es einen Schlusskurs von mindestens $1,00 für mindestens zehn aufeinanderfolgende Handelstage beibehält.

Die Mitteilung hat keinen sofortigen Einfluss auf die Listung oder den Handel der Aktie an der Nasdaq. Scienture ist zuversichtlich, die Einhaltung wiederherstellen zu können, weist jedoch darauf hin, dass es keine Gewähr gibt, dass die Anforderungen oder andere Nasdaq-Kriterien erfüllt werden.

Scienture Holdings (SCNX) أعلنت أنها تلقت إشعاراً من Nasdaq يفيد بأن أسهمها العادية لم تستوف الحد الأدنى لسعر العرض البالغ $1.00 لمدة 30 يوماً عملياً متتالياً، مما أدى إلى تشغيل فترة الامتثال. لدى الشركة 180 يوماً تقويمياً حتى 13 أبريل 2026 لاستعادة الامتثال من خلال الحفاظ على سعر إغلاق عند أو فوق $1.00 لمدة عشرة أيام عمل متتالية على الأقل.

لا يترتب على الإشعار تأثير فوري على إدراج أو تداول الأسهم في Nasdaq. تعتقد Scienture بأنها يمكن أن تستعيد الامتثال، مع الإشارة إلى أنه لا يوجد ضمان بأنها ستفي بالمتطلبات أو بمعايير Nasdaq الأخرى.

Scienture Holdings (SCNX) 披露其收到了纳斯达克的通知,其普通股未能在连续30个交易日内达到<$1.00的最低竞价价格,触发合规期。公司有180日历日,直到2026年4月13日,通过将收盘价维持在< b>$1.00及以上且至少十个交易日的连续性,来恢复合规。

该通知对在纳斯达克的上市或交易没有即时影响。 Scienture 相信有能力恢复合规,但指出并不能保证它会满足该要求或纳斯达克的其他标准。

Positive
  • None.
Negative
  • None.

Insights

Nasdaq bid-price deficiency with a defined 180-day cure window.

SCNX has been below the $1.00 bid threshold for 30 consecutive business days, triggering a standard Nasdaq compliance process. The company now has 180 calendar days—until April 13, 2026—to post a closing bid at or above $1.00 for ten straight trading days.

The notice explicitly carries no immediate listing or trading impact. Outcomes depend on future trading levels or corporate actions the company may pursue, if any. If the minimum is met for ten consecutive days within the window, compliance is restored; otherwise, additional Nasdaq procedures may follow per exchange rules.

Scienture Holdings (SCNX) ha comunicato di aver ricevuto una notifica Nasdaq per cui il suo titolo azionario comune non ha rispettato il prezzo minimo di negoziazione di $1,00 per 30 giorni lavorativi consecutivi, attivando un periodo di conformità. L'azienda ha 180 giorni di calendario, fino al 13 aprile 2026, per ritornare a conformità mantenendo una chiusura di negoziazione pari o superiore a $1,00 per almeno dieci giorni lavorativi consecutivi.

La notifica non ha effetto immediato sulla quotazione o sul trading del titolo su Nasdaq. Scienture ritiene di poter ritornare in conformità, pur rilevando che non vi è alcuna garanzia che verrà soddisfatto il requisito o altri criteri Nasdaq.

Scienture Holdings (SCNX) anunció haber recibido una notificación de Nasdaq que su acción ordinaria no cumplió con el precio mínimo de puja de $1.00 durante 30 días hábiles consecutivos, desencadenando un periodo de cumplimiento. La empresa tiene 180 días naturales, hasta el 13 de abril de 2026, para volver a cumplir manteniendo un precio de cierre de al menos $1.00 por diez días hábiles consecutivos.

La notificación no tiene efecto inmediato en la cotización ni en el listado en Nasdaq. Scienture cree que puede volver a cumplir, aunque advierte que no hay garantía de que se cumpla el requisito u otros criterios de Nasdaq.

Scienture Holdings (SCNX)는 보통주가 30영업일 연속으로 $1.00의 최저 호가를 충족하지 못했다는 나스닥 통지를 받았으며, 이를 통해 규정 준수 기간이 시작되었습니다. 이 회사는 180일의 캘린더링 기간이 남아 있으며, 2026년 4월 13일까지, 최소 $1.00의 종가를 10영업일 연속 유지하여 규정 준수를 회복할 수 있습니다.

이 통지는 나스닥에서의 상장 또는 거래에 즉시 영향을 주지 않습니다. Scienture은 규정을 회복할 수 있을 것으로 믿고 있으며, 요구사항이나 다른 나스닥 기준을 충족할 것이라는 보장은 없다고 덧붙입니다.

Scienture Holdings (SCNX) a publié avoir reçu un avis de Nasdaq indiquant que son action ordinaire n'a pas respecté le prix d'offre minimum de $1,00 sur 30 jours ouvrables consécutifs, déclenchant une période de conformité. La société dispose de 180 jours calendaires, jusqu'au 13 avril 2026, pour retrouver la conformité en maintenant un cours de clôture au moins égal à $1,00 pendant au moins dix jours ouvrables consécutifs.

Cet avis n'a pas d'effet immédiat sur l'inscription ou la négociation des actions sur Nasdaq. Scienture estime pouvoir retrouver la conformité, tout en notant qu'il n'y a aucune assurance qu'elle remplira l'exigence ou d'autres critères de Nasdaq.

Scienture Holdings (SCNX) gab bekannt, dass es eine Nasdaq-Mitteilung erhalten hat, wonach seine Stammaktie in 30 aufeinanderfolgenden Handelstagen den Mindestangebotspreis von $1,00 nicht erreicht hat, wodurch eine Compliance-Periode ausgelöst wurde. Das Unternehmen hat 180 Kalendertage bis zum 13. April 2026, um die Einhaltung wiederherzustellen, indem es einen Schlusskurs von mindestens $1,00 für mindestens zehn aufeinanderfolgende Handelstage beibehält.

Die Mitteilung hat keinen sofortigen Einfluss auf die Listung oder den Handel der Aktie an der Nasdaq. Scienture ist zuversichtlich, die Einhaltung wiederherstellen zu können, weist jedoch darauf hin, dass es keine Gewähr gibt, dass die Anforderungen oder andere Nasdaq-Kriterien erfüllt werden.

false 0001382574 0001382574 2025-10-14 2025-10-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 14, 2025

 

SCIENTURE HOLDINGS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   001-39199   46-3673928

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(I.R.S. Employer

Identification No.)

 

6308 Benjamin Rd, Suite 708

Tampa, Florida 33634

(Address of Principal Executive Offices)

 

(866) 468-6535

(Registrant’s Telephone Number)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.00001 per share   SCNX   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On October 14, 2025, Scienture Holdings, Inc. (the “Company”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock, par value $0.00001 (“Common Stock”) had been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). According to that notice, the Company has 180 calendar days, or until April 13, 2026, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the minimum bid price of the Company’s Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-calendar day grace period.

 

This written notice has no immediate effect on the listing or trading of the Company’s Common Stock on Nasdaq. The Company believes it will be able to timely regain compliance with Nasdaq’s continued listing requirements. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be able to maintain compliance with other Nasdaq listing criteria.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
     
104   Cover Page Interactive Data File (embedded with the Inline XBRL document).

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SCIENTURE HOLDINGS, INC.
     
  By: /s/ Dr. Narasimhan Mani
    Dr. Narasimhan Mani
    Co-Chief Executive Officer
     
Date: October 17, 2025    

 

 

 

 

FAQ

What did Scienture Holdings (SCNX) announce regarding Nasdaq listing compliance?

The company received a Nasdaq notice that its stock was below the $1.00 minimum bid price for 30 consecutive business days.

How long does SCNX have to regain compliance with Nasdaq’s bid price rule?

SCNX has 180 calendar days, until April 13, 2026, to regain compliance.

What is required for SCNX to regain Nasdaq bid price compliance?

The stock must close at or above $1.00 per share for at least ten consecutive business days within the 180-day period.

Does the Nasdaq notice immediately affect SCNX’s trading status?

No. The notice has no immediate effect on the listing or trading of the stock on Nasdaq.

Did SCNX comment on its ability to regain compliance?

Yes. The company stated it believes it can regain compliance, but gave no assurance that it will do so.
Scienture Holdings, Inc

NASDAQ:SCNX

SCNX Rankings

SCNX Latest News

SCNX Latest SEC Filings

SCNX Stock Data

12.54M
19.31M
25.78%
1.56%
0.67%
Pharmaceutical Retailers
Pharmaceutical Preparations
Link
United States
COMMACK